BRITTANY WALL: Open Payments
NPI 1639835432 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 37 payments from 16 companies in 2025. Trend: 2023 $680 · 2024 $638 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $118 |
| ABBVIE INC. | 5 | $116 |
| Novo Nordisk Inc | 6 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Amgen Inc. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Grifols USA, LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: ELIQUIS, Ozempic, QULIPTA, CAPLYTA, OTEZLA, BREZTRI, PREVNAR 20, Wegovy.
Industry payments across NC — which companies pay providers there.
